Author

Lewis Hendrianto

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Heather EliasseniD· 1 shared Alanis Carmona· 1 shared Andrew J. AguirreiD· 1 shared Aparna PadhyeiD· 1 shared Bin Zou· 1 shared Brendan D. ParentiD· 1 shared Bryan K. S. YeungiD· 1 shared Cameron S. FraseriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Heather EliassenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer

Jonathan M. DeLiberty, Fan Yi Kong, Qijia Yu, Nicole Sindoni, Johnson Lin, Kalisa Kang, Elizabeth Y. Kim, Sabrina Chen, Aparna Padhye, Oluwadara Coker, Joshua H. Choe, Joao A. Paulo, Myungsun Shin, Lewis Hendrianto, Kazuki Takahashi, , Joseph Douglas Mancias

This study identifies ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer by analyzing proteomic changes induced by KRAS inhibition and developing an antibody drug conjugate.

bioRxiv · Oct 2, 2026 · PreprintCancer Biology

Plasma plasmalogen levels and risk of lymph node positive breast cancer

Mahsa Yavari, Kristen D. Brantley, Alanis Carmona, Marie Sabatier, Yanshan Liang, June Monge-Lorenzo, Jordan Torpey, Krystina J. Szylo, Midori R. Flores, Mario Palma, Cameron S. Fraser, Milena Chaufan, Mayher Kaur, Lewis Hendrianto, Whitney S. Henry, , Jessalyn M. Ubellacker

The paper links lower plasma plasmalogen levels to increased risk of lymph node positive breast cancer in humans and mice, showing dietary PUFA depletion promotes cancer survival in lymph nodes.

bioRxiv · Dec 15, 2025 · PreprintCancer Biology